Oppilan Pharma Ltd reported raising $4.25 Million in an initial SEC Form D filing, from an offering of $12 Million
Amount Raised
$4.25 Million
Round Type
Seed
Quick answer
Oppilan Pharma Ltd raised $4.25 Million in a Seed round, dated December 30, 2016. Oppilan Pharma Ltd is based in United Kingdom.
- How much did Oppilan Pharma Ltd raise?
- Oppilan Pharma Ltd raised $4.25 Million in a Seed round on December 30, 2016.
- Where is Oppilan Pharma Ltd based and how big is it?
- Oppilan Pharma Ltd is based in United Kingdom.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Oppilan Pharma Ltd that raised within 45 days of this round, from Fundz verified event records.
- Reshape Medical, Inc. raised $11M on February 13, 2017.
- AIM ImmunoTech raised $18K (Pre-Seed) on February 13, 2017.
- Oleander Medical Technologies raised $150K (Pre-Seed) on February 13, 2017.
- Gila Therapeutics, Inc. raised an undisclosed amount on February 13, 2017.
- Pediatrix Medical Group raised $513K (Seed) on February 10, 2017.
- MOLECULARMD CORP. raised $2.1M (Seed) on February 10, 2017.
Who to call at Oppilan Pharma Ltd, and when
A new round usually means Oppilan Pharma Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oppilan Pharma Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oppilan Pharma Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oppilan Pharma Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oppilan Pharma Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Oppilan Pharma Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.